Regulatory Roundup: Week of August 13: ISPE Issues Ozone Sanitization Guidance and EMA Amends Incident Management Plan - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: Week of August 13: ISPE Issues Ozone Sanitization Guidance and EMA Amends Incident Management Plan


ISPE has issued ISPE Good Practice Guide: Ozone Sanitization of Pharmaceutical Water Systems, a new guidance document on the design and use of ozone systems for pharmaceutical water sanitization. The guide offers insight on ozone sanitization systems, including regulatory considerations, system operation, and qualification of ozone systems, to allow pharmaceutical companies to better understand ozone systems.

The European Union Regulatory Network Incident Management Plan for Medicines for Human Use has been amended by EMA to reflect 2010 pharmacovigilance legislation. The plan, in operation since September 2009, explains how safety and other drug incidents are monitored and addressed by the EMA, the European Commission, and regulatory agencies across the EU.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
11%
Protecting the supply chain
39%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here